By Seth Borenstein

NASA’s new space telescope has gazed into the distant universe and shown perfect vision: a spiky image of a faraway star photobombed by thousands of ancient galaxies.

The image released Wednesday from the James Webb Space Telescope is a test shot — not an official science observation — to see how its 18 hexagonal mirrors worked together for a single coordinated image taken 1 million miles (1.6 million kilometers) away from Earth. Officials said it worked better than expected.

Last month, NASA looked at a much closer star with 18 separate images from its mirror segments.

Scientists said they were giddy as they watched the latest test photos arrive. NASA’s test image was aimed at a star 100 times fainter than the human eye can see — 2,000 light-years away. A light-year is nearly 6 trillion miles (9.7 trillion kilometers).

The shape of Webb’s mirrors and its filters made the shimmering star look more red and spiky but the background really stole the show.

“You can’t help but see those thousands of galaxies behind it, really gorgeous,” said Jane Rigby, Webb operations project scientist.

Those galaxies are several billions of years old. Eventually, scientists hope Webb will see so faraway and back in time that it will only be “a couple hundred million years after the Big Bang,” she said.

The first science images won’t come until late June or early July.

The $10 billion Webb — successor to the nearly 32-year-old Hubble Space Telescope — blasted off from South America in December and reached its designated perch in January.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
One Good Thing: All 14 Patients in Experimental Trial Saw Cancer Go Into Remission
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
A New Plant-Based Way to Quit Smoking
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
Plant-Based Way to Quit Smoking; Innovation in Stroke Therapy
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Load More